GLP-1 Receptor Agonist GLP-1, or glucagon-like peptide-1, is a hormone that plays a vital role in controlling blood sugar and appetite
This strategy is particularly popular among those using compounded formulations where syringe dosing allows for precise volume measurements
The date has passed
Contraindications that apply regardless of dose: Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Prior serious hypersensitivity to tirzepatide Pregnancy or breastfeeding Active pancreatitis or a history of severe pancreatitis Severe gastroparesis Adverse events that can occur at any dose: nausea, vomiting, diarrhea, constipation, abdominal pain, gallbladder disease, acute kidney injury from dehydration, injection-site reactions, and rare cases of pancreatitis
However, as blood sugar decreases, the kidneys may need to process and expel excess glucose
Semaglutide is a GLP-1 receptor agonist used to support weight loss by regulating appetite and improving metabolic function